Dudley Robert Michael Insider Trades

Insider Trading History

Track insider trading activity for Dudley Robert Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
TransCode Therapeutics
TransCode Therapeutics RNAZ
Chief Executive Officer
Holding Value $1.05M 180,262 shares
Last Trade
Sep 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.46B 98,000 shares
$14,880.32
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
Chief Executive Officer
Holding Value $480k 82,262 shares
Last Trade
Jun 21, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$841M 12,000 shares
$70,113.12
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
Chief Executive Officer
Holding Value $410k 70,262 shares
Last Trade
Jun 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$451M 6,607 shares
$68,302.08
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
Chief Executive Officer
Holding Value $357k 61,155 shares
Last Trade
Jun 09, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.37B 19,000 shares
$71,924.16
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
Chief Executive Officer
Holding Value $5.33M 912,114 shares
Last Trade
Jun 09, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.37B 19,000 shares
$71,924.16
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
Chief Executive Officer
Holding Value $4.29M 735,000 shares
Last Trade
May 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108B 735,000 shares
$147,156.80
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
Chief Executive Officer
Holding Value $788k 135,000 shares
Last Trade
Dec 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.6B 135,000 shares
$263,894.40
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
10% owner, Chief Executive Officer
Holding Value $5.22M 893,114 shares
Last Trade
Sep 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.9B 20,000 shares
$595,056.00
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
Chief Executive Officer
Holding Value $5.09M 871,114 shares
Last Trade
May 27, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.5B 28,000 shares
$946,915.20
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
10% owner, Chief Executive Officer
Holding Value $788k 135,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$171B 135,000 shares
$1,267,673.12
$5.84
TransCode Therapeutics
TransCode Therapeutics RNAZ
10% owner, Chief Executive Officer
Holding Value $4.92M 843,113 shares
Last Trade
Jul 08, 2021 Sale
No data
No data
$5.84

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up